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Because the effects of epigenetic (gene-environment interaction) changes have been associated with numerous adverse health states,
the study of epigenetic measures provides exciting research opportunities for biobehavioral scientists. However, recruitment for
studies focusing on any aspect of genetics poses challenges. Multiple factors, including lack of knowledge regarding a research
study, have been identified as barriers to recruitment. Strengthening the informed consent process through extended discussion
has been found to be effective in recruiting for research studies in general, yet there is a paucity of information that focused on such
a recruitment strategy for epigenetic studies. In this paper, we share our experiences with strategies to strengthen the informed
consent process as well as provide samples of materials developed to heighten potential participants’ understanding of epigenetics, in
4 epigenetic research studies with women from diverse backgrounds experiencing a range of health issues. The combined enrollment
success rate for epigenetic studies using the process was 89% with participants representing a diverse population. We posit that
carefully developed recruitment scripts provided a foundation for improving potential participants’ understanding of the research
project. Easy to understand illustrations of the epigenetic process provided a basis for active engagement and encouraged individual
questions.

1. Introduction
Recruitment, the process of identifying and enrolling eligible
participants in a research study, is a fundamental component
of all clinical research endeavors [1, 2]. While there are
published reports identifying strategies to identify potential
research participants for research studies in general [3–10],
the published literature focusing on recruiting specifically for
genetic research in the USA is limited [11–16], and there is
a paucity of studies specific to recruitment and enrollment
strategies in epigenetic research.
This gap in the literature poses a significant problem given
the importance of epigenetic research. In the past few years,
our understanding of the causal factors leading to complex
diseases has expanded to include not only the recognition
of causal factors due to an individual’s DNA sequence
(including polymorphisms), but also the identification of
epigenetic changes that result from environmental/social

experiences (referred to as gene—environment interactions).
This paradigm shift has resulted from a better understanding
of epigenetic factors that are involved in human health and
illness [17]. Epigenetics is the study of the changes in gene
expression, the mitotic inheritance of patterns of gene expression, and nuclear inheritance which is not based on changes
in DNA sequence [18]. These additions to the understanding
of the genomic revolution have demonstrated the importance
of studying the influence of the environment on (epi) genetic
mechanisms [19]. Epigenetic changes can switch genes on
or off and determine which proteins are transcribed [17].
Environmental factors, in the context of both the external
and internallymodulated environment, such as behavior patterns, nutrition, stress, and toxins/pollution, can influence
gene expression [19, 20]. The deleterious effects of these
epigenetic changes have been associated with diverse conditions including but not limited to, accelerated aging, heart
disease, diabetes, obesity, cancer, and mental disorders [21].

2
Therefore, for biobehavioral scientists, the study of epigenetic measures provides exciting opportunities to identify
meaningful relationships among potentially modifiable environmental and life-style variables, with the potential for
the future development of targeted interventions to improve
health outcomes.
Epigenetic measures, such as DNA methylation and
histone modification, have only recently been incorporated
into human clinical research. While there are many potentially important reasons for examining these measures in
clinical studies, the process of explaining these concepts and
measures to potential study participants is compounded not
only by the complexity of the concepts but also the shift in the
understanding of genetics from a “gene-centric” view of the
former genetic paradigm [22] to the “phenotypic plasticity” of
a given genotype to produce different phenotypes in response
to different environments [23].
Although there are still many unknowns in the integration of epigenetic measures into clinical research, future
knowledge development depends on beginning to include
these measures in research studies. In human research,
recruiting potentially eligible research participants is one
of the key challenges. However, recruiting and enrolling
eligible participants for research focusing on any aspect of
genetics pose particular challenges. Multiple factors have
been identified that can adversely affect the rate of participant
accrual into clinical research. For example, mistrust, health
status, language, literacy, and lack of knowledge regarding
a research study have been identified as barriers to recruitment [5]. These barriers may be even more magnified in
low income, minority, or otherwise vulnerable populations
resulting in further difficulties to include diverse participants
[24]. Consequently, investigators conducting research of a
genetic nature may experience even more challenges than
other fields regarding the underrepresentation of vulnerable
and/or minority populations [25, 26].
One avenue for decreasing potential barriers and improving recruitment is to strengthen the informed consent
process. This could be accomplished by considering the
cultural and contextual issues that surround the potential
participant’s reactions to informed consent, the comprehension of information delivered during the process, and the
ability of researchers to address these issues [27]. There is
evidence to suggest that such a strategy is potentially effective
when recruiting for research studies in general [28], yet
there is a paucity of published literature that focused on
such a recruitment strategy for epigenetic studies. Obtaining
informed consent is an essential process by which potential
study participants are presented with the opportunity to make
informed decisions about their participation in research [27].
An informed consent document should always include an
explanation of the study, a description of risks, benefits,
and confidentiality, methods to contact the investigators in
the event of adverse events or questions, a statement that
participation in the study is voluntary, and procedures for
withdrawing from the study [29, 30]. However, this document
alone does not typically allow for interested individuals to
share their thoughts, feelings, or concerns about participating
in the study. In addition, the Declaration of Helsinki suggests
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that the well-being of study participants should be the priority
of the researcher, thus it is important to ensure that potential
participants are comfortable talking with researchers about
any concerns [31]. It is prudent to view informed consent as
having two components: (1) the written information shared
and signed by all participants and (2) the process by which
the research team provides the information and answers
questions [32].
Often the focus of informed consent may be on the
actual signing of the consent document rather than on
the interaction between the researcher and participant to
ensure that communication and understanding have been
achieved [27]. This focus seems ill-advised, as standard
consent forms with their technical language, multiple sections, and length can impede a participant’s understanding
[33, 34] which, in turn, may undermine the recruitment
and retention of participants [35]. While limited, there is
evidence to suggest that additional information provided to
potential participants outside the formal consent document
may increase their knowledge and have a positive effect
on participant recruitments for several types of studies,
including clinical trials involving patients with advanced
cancer [36]: African American outpatients [37], pregnant
women [38], and women being screened or treated for breast
cancer [39]. These results provide support for the premise
that strengthening the informed consent process, through an
increased understanding of information, may be a potential
avenue for improving unbiased recruitment [27].
In this paper, we share our experiences with strategies to
strengthen the informed consent process as well as provide
samples of materials developed to heighten potential participants’ understanding of epigenetics, in 4 epigenetic research
studies with women from diverse backgrounds experiencing
a range of health issues. As nurse scientists at the Virginia Commonwealth University School of Nursing, we are
investigating relationships between epigenetic changes and
psychobiologic symptom measures in women of varying ages,
ethnicity/race as well as health status, and we have recognized
the potential benefit of strengthening the informed consent
process.
Aim. This paper is a process evaluation of the extended
discussion strategy the authors developed and implemented
to enhance recruitment enrollment in 4 separate research
studies. Therefore, the aim of this paper is to (1) describe the
development and implementation of an expanded informed
consent process; (2) provide samples of the recruitment materials developed to heighten potential participants’ understanding of epigenetics; and (3) report the overall enrollment
rate in the 4 studies using this process.

2. Materials and Method
2.1. Design. After reviewing the literature to identify which
strategies may be most effective in improving potential participant’s understanding of the research study, we concluded
that a successful consent process is likely to require one-toone interaction with someone knowledgeable about the study
[28, 40]. Extended discussion between the research team
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and potential study participants has resulted in statistically
significant increases in participants’ understanding [41–43].
For example, patients having cancer who received a standard
informed consent procedure supplemented with a telephonebased informational contact session by a nurse were found
to be significantly more informed about a research study
compared to those receiving standard informed consent
procedures from the treating physician [41]. Similarly, in
a study among poor, urban potential research participants,
comprehension of the consent form increased following
extended discussion with a counselor before meeting with the
study investigator [43]. Also, cardiac patients demonstrated
an increase in understanding with repeated education about
the research protocol [42]. In addition, discussions with the
research team to review the research and informed consent
document were found to be preferred in 97% of low-income
and minority women compared to reading it themselves [44].
Taken in total, these studies provide evidence to suggest
that extended person-to-person interactions and discussions
enhance participant understanding. However, no similar
strategy has been used nor evaluated in epigenetic research,
a topic of increased interest to many researchers. To address
this gap, the authors developed and implemented research
materials designed to heighten eligible participants’ understanding of epigenetics to strengthen the informed consent
process.
Several other factors were considered in the development
of the recruitment materials. We acknowledged that the
language of epigenetics might be difficult for the layperson
to understand. Words used in epigenetic research, such
as epigenetics, telomeres, and DNA methylation, are most
likely unfamiliar to potential study participants and may
be confused with genetic research. To meet this challenge,
we developed a basic recruitment script that strived to use
“plain language” or “plain English” that is straightforward and
easy to understand [45]. It would come as no surprise that
information delivered in plain language appeals to patients
[46] and is related to increased satisfaction and decreased
anxiety with the informed consent process [18]. In addition,
we employed metaphors to clarify potentially unfamiliar
concepts since every day examples can be valuable tools of
communication when attempting to clarify complex concepts
[47]. For example, metaphors such as “our bodies are made
up of cells, much like a beach is made up of small grains of
sand” or “genes can be turned on and off just like lights in
your house can be turned on and off ” were added to increase
understanding. The initial script was reviewed by experts in
health policy and the national genetic service sector, as well as
African American, Hispanic, and Caucasian women of ages
similar to potential study participants. The script was then
revised based on their comments.
The basic script served as the framework for the extended
discussion but was tailored to meet the experiences and
concerns of potential participants from diverse backgrounds
[48]. For example, with potential participants who were
pregnant, the researcher added to the basic script assurances
that the study was not looking for, or testing for, any genetic
problem in the baby. An example of the basic recruitment
script is included (Appendix A).
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Epigenetic recruitment scripts were supplemented with a
list of Frequently Asked Questions (FAQs). The contents of
this list were based on comments from the reviewers of the
script as well as feedback from researchers experienced in
epigenetic research. The proposed answers to the FAQs were
designed to be straightforward and also included metaphors.
For example, when asked “can you find anything bad,” the
proposed answer was intended to reassure the potential
participant. The answer that stated “We are not looking
at inherited changes that cause people to have genetic or
inherited diseases. We are looking at things that might turn
genes on and off in our body’s cells. To use our house
analogy, we are not looking at how the wiring in the house is
designed, but rather changes in how the appliances plugged
into the wiring are used” may help the potential participant
to understand the goal of the research. The FAQs were viewed
as tools to assist the research team in addressing questions or
issues that may arise. Samples of Frequently Asked Questions
are provided (Appendix B).
2.2. Research Studies and Participants. The cohort for this
report of our epigenetic informed consent process was created by combining the recruitment and data collection efforts
of 4 individually funded research studies. While separate,
each study is related through the epigenetic aim. Table 1
summarizes the aims, target population, and recruitment
goals of the four studies. The author researchers incorporated the recruitment materials into their individual study
protocol. Participants for the 4 studies were recruited from
health care providers’ offices and the community in an
urban metropolitan as well as rural area in the Southeast
area of the United States. Participants in previous research
studies who had expressed interest in future studies were also
contacted. Recruitment methods included use of brochures
and flyers placed in physician offices, ambulatory care clinics, and churches; newspaper ads; referrals from clinical
and community partners; and face-to-face personal recruitment. Depending on the research design, person-to-person
extended discussions occurred either face to face or over the
phone and typically lasted for 15–20 minutes.
2.3. Data Analysis. Descriptive statistics were used to analyze demographic data and calculate the enrollment rate
or recruitment yield. The recruitment rate represents the
number of participants enrolled divided by the number of
participants eligible for the study.
2.4. Ethics. Ethical approval for all studies was obtained from
the Virginia Commonwealth University Institutional Review
Board.

3. Results
3.1. Recruitment Demographics and Yield. The cohort for this
paper, which is a reporting of our process evaluation, is a
convenience sample of 102 women enrolled in one of the four
epigenetic studies. The participants ranged in age from 18–
71 years. The mean age of participants was 46. The majority
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Table 1: Overview of studies.
Recruitment
goal

Research title

Epigenetic aim

Population

Epigenetics and psychoneurologic (PN)
symptoms in women with breast cancer
(Lyon et al.)

(1) Longitudinally examine levels of
inflammation and epigenetic patterns
pre-, peri-, and postchemotherapy
(2) Longitudinally examine relationships
among inflammation, epigenetic changes,
and PN symptoms

Women diagnosed with
early-stage breast cancer

𝑁 = 75

Longitudinally examine relationships
among epigenetic changes, stress, anxiety,
depression, and stress biologic markers

Low-income healthy
pregnant women

𝑁 = 10

Women with fibromyalgia

𝑁 = 10

Women with treatmentresistant depression

𝑁 = 10

Epigenetics and maternal stress
(supplement to ongoing intervention
trial)
(Jallo and Cook)
Stress, immunity and symptoms in
Fibromyalgia
(Menzies and Cook)
Effects of yoga for women with
depression
(Kinser and Cook)

Examine relationships among stress,
inflammation, environment, fibromyalgia
symptoms, and gene expression
Examine relationships among depression,
stress, inflammation, cellular aging, DNA
methylation patterns, and yoga

Table 2: Results of 4 research studies using the enhanced informed consent process.
Research title
Epigenetics and
psychoneurologic (PN)
symptoms in women with
breast cancer
(Lyon et al.)
Epigenetics and maternal
stress
(supplement to ongoing
intervention trial)
(Jallo and Cook)
Stress, immunity and
symptoms in fibromyalgia
(Menzies and Cook)
Effects of yoga for women
with depression
(Kinser and Cook)

Population

Age range
(years)

Ethnicity/race
(self-identified)

Enrollment rate
(recruitment yield)

Women diagnosed with
early-stage breast cancer

23–71

African American, 50%
Caucasian, 50%

80%

Healthy pregnant women

18–32

African American, 100%

85%

Women with fibromyalgia

44–62

Women with
treatment-resistant
depression

21–61

of the sample was Caucasian (𝑛 = 61/102) which is 60% of
the total sample. African American participants represented
38% of this sample (39/102). The total enrollment for African
American women from the urban center for this study is
greater than 50% (16/31). The combined sample also includes
1% Asian participants and 1% of the participants are Hispanic.
The average success rate for enrollment for these studies
combined to date (𝑛 = 102) was 89%. The findings are
provided in Table 2.
3.2. Participant Comments. Of the eligible participants who
decided not to enroll, the majority cited the following reasons
for not enrolling: (1) feeling overwhelmed by the situation
of having cancer and the treatment schedules; (2) concern
over being anemic and having additional blood being drawn;
(3) not wanting blood drawn at time of study since “just
stuck yesterday at the doctor’s office.” No potential eligible

Caucasian, 50%
African American, 40%
Hispanic, 10%
Caucasian, 44.4%
African American, 44.4%
Asian, 11.1%

100%

90%

participant stated concern over the concept of epigenetics or
aims of the study as reasons for refusal.

4. Discussion
The aim of this report of our epigenetic recruitment process
was to describe the development and implementation of
recruitment materials developed to expand the informed
consent process to heighten potential participants’ understanding of epigenetics. We report the overall enrollment rate
in the studies using these tools as a potential proxy measure
for their efficacy. Because there is a paucity of epigenetic
recruitment literature, we frame our discussion within the
context of genetic research recruitment.
The overall rate of enrollment was 89% using our
enhanced informed consent process, higher than reported
rates from other genetic studies conducted in the USA
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which ranged from 15.9% to 84.9% ([13, 15, 16, 49–51]. For
example, researchers recruiting adults with temporal lobe
epilepsy reported that, of the eligible patients, 15.9% enrolled
in genetic studies [13]; another study reported that 57% of
the mostly Caucasian potential participants consented [49];
62.3% of eligible African American and Latinos participated
in a lung cancer study [15]; the Agricultural Health study
obtained informed consent from 79% of those male farmers
contacted [50]; and the NHAMES study reported that 84.8%
in the 2000 survey of eligible participants representative of
the general population consented to have DNA stored in a
national repository [51]. The rate of enrollment in this study
was slightly lower than that in the Action for Health in
Diabetes clinical trial which reported an overall enrollment
rate of 89.6% across 15 institutions conducting DNA research
among overweight or obese individuals with type 2 diabetes
[16].
Participation in research is often lower among women
in general as well as members of minority racial/ethnic
groups, which may pose a challenge when recruiting for
epigenetic research [14, 16]. For example, females and nonHispanic blacks consistently had lower consent rates compared to representative sample of the USA population [51].
Similar findings were reported by Espeland et al. [16] who
found nonconsent occurred more frequently among AfricanAmerican, Hispanic, and female potential participants. We
did not encounter this phenomenon. Participants in this
cohort study represented a diverse population of Caucasian,
African American, Asian, and Hispanic participants. Study
participants from minority ethnic/racial groups comprised
40% of our combined cohort, which represents the profile
of our community’s population (U.S. Census Bureau). The
ethnic/racial categories of our participants are presented in
Table 2.
Due to several study limitations, the high enrollment rate
cannot be attributed solely to the efficacy of the expanded
discussion and recruitment materials. Because there was no
randomization, the high rate of enrollment could be the
result of factors other than the expanded informed consent
process. The small sample size of the pilot studies limits
generalizability. In addition, the willingness of these women
to join an epigenetic study may be attributed to the prior
experience and the established relationships between the
potential study participant and the researcher [9]. Also,
because there were 4 separate studies with different research
teams, the possibility of recruitment variance cannot be ruled
out. While the recruitment materials did provide consistency
of information delivered, individual interactions with eligible
participants may have influenced enrollment [52].
While our results must be balanced with study limitations, we suggest that the materials we implemented to
improve the informed consent process contributed to our
success in recruiting diverse samples for our studies. We posit
that carefully developed recruitment scripts provided a foundation for improving potential participants’ understanding
of the research project. Easy to understand illustrations of
the epigenetic process provided a basis for active engagement
and encouraged individual questions. The frequently asked
question section was a way for prospective participants to
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understand that it was “normal” to have questions and to want
more information about a specific research study in which
they were eligible for enrollment. Using familiar words and
ideas to simplify information and teach potential participants
is considered an important component to successful participant recruitment [45].
The basic recruitment script, as well as the FAQs document, established consistency among members of the
research team, encouraged engagement in conversation with
each participant to ensure understanding, and provided an
opportunity to address participants concerns. We suggest that
by incorporating the FAQs and the extended discussion into
our individual protocols, we may have positively impacted
recruitment into our various epigenetically focused research
studies; thus this may be a potential strategy for strengthening
future informed consent processes.

5. Conclusion
Recruiting for genetic and epigenetic studies will be an
ongoing challenge for scientists conducting research in
human subjects. We believe that expanding the information
and dialogue involved in the informed consent process is
a foundational step for further participants to accept of
their active engagement in research studies. In epigenetic
studies, it is important to view informed consent as a process
that depends on interactions between the researcher and a
potential participant. Continued success with implementing
biobehavioral research depends on the careful development
of strategies that create a safe and open environment for
dialogue among research scientists and potential research
participants.

Appendices
A. Example of Basic Recruitment Script
Our bodies are made up of cells, much like a beach is made
up of small grains of sand. Within every cell we have genes.
These genes contain the biologic instructions that tell our cells
how to work. A portion of these genes can be turned on or
off in response to our exposures or stress experiences and we
are trying to learn how this process works. One question that
we are asking in this part of the study is if there are some
(fill in the blank with
genes that turn on or off in a
appropriate study aim: for example, mother’s body during
pregnancy; women with fibromyalgia). We are also interested
in trying to learn what environmental or situational events
trigger these changes.
One way to picture this concept is to think of our body as
a house. In your house there is wiring that is present, much
like the way that there our genes present in our body. Some of
the items that are plugged into the wiring are always on (like
the refrigerator). These items are comparable to the group of
genes that we have in our bodies that are also always turned
on. However, there are some items that you turn on and off
in response to your needs. For example, you may walk into
different rooms and flip switches to turn the lights on or off.
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A portion of these devises are easily changed in response to
needs (for example flipping lights on or off). However there
are some devises that, once an initial change is made, require
more effort to reverse. For example, when a lot of devices
are used on one circuit or when there is some sort of power
surge you can flip a breaker in a house. To get the electric
to work again for that subset of devices you have to identify
where the change occurred (which breaker flipped) and then
actively flip the switch back to regain the original function.
The options for having devices working in your home is a
combination of the wiring that is present (our genes), adding
devices and turning them on or off (our environment) and
then using (or not using) the device, such as using the light to
read by, watching the TV, or having a dark room for sleeping
(changes in the cells). We are interested in learning about
the types of changes that arise in a mother’s body during
pregnancy (turning devices on and off) and the interactions
that influence if these changes occur and if so, for how long.

B. Frequently Asked Questions
Can you tell if my baby has a problem?
No, we are not looking for or testing for any genetic
problems with the baby. Your provider may talk to you
about some potential prenatal screening tests for this
reason but we are not testing the baby for any genetic
conditions.
Could you find anything “bad”?
We are not looking at inherited changes that cause
people to have genetic diseases. Instead we are looking
at factors that might turn genes on and off in our
body’s cells. To use our house analogy, we are not
looking at how the wiring in the house is designed
but rather changes in how the devices plugged into
the wiring are used.
Will you provide me with the results of these tests?
No since this is a very new study, we do not know how
important any of the findings will be. Because we are
just beginning to look at how the body’s cells might
turn on and off with stress, it is too early to provide
you with any individual report or information. By
participating in this study you would be providing
the first gains in our knowledge about these types of
changes.
Will anyone see these results?
The results of this study will not be provided to you
or your doctor. They will not be in your health record
nor will the results have any effect on your treatment.
All of the information gained will be kept strictly
confidential to ensure that your privacy is protected.
Will there be any extra costs for these studies?
No, since this is a research project you will not have
any costs extra.

Will giving extra blood be harmful to my baby or me?
While the filled tubes look like they have a lot
of blood, you are actually providing only about 2
tablespoons of blood. This will not have any bad
impact on your health or the health of your baby.
For comparison, when people donate blood a pint is
collected and even taking that much blood has no bad
effects.
If you do not know if there are any changes, why should I
participate?
You are correct; at this time we do not know if there
will be any changes. That is why this is considered
to be a research test. The only way we can gain
knowledge is by studying people who are pregnant to
learn if these changes occur. Our hope is that if we
can identify consistent changes that occur in women
with specific types of health concerns during their
pregnancy then we can develop methods in the future
that might help us to treat women or develop lifestyle
changes to help women avoid these problems during
their pregnancy.
How will I know about my DNA?
None of this blood work is used to diagnose or treat
you. We are looking at relationships of “markers” and
symptoms. We do not share your results with anyone.
Again, we look at averages and compare those. We will
not be giving lab results to you because yours alone is
not the primary focus of this work.
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